Englander Institute for Precision Medicine
Found 797 results
Author Title Type [ Year(Desc)]
Filters: Clinical-trials-corner-issue-10(1) is   [Clear All Filters]
2024
Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV.  2024.  Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer.
Niso-Santano M, Fuentes JM, Galluzzi L.  2024.  Immunological aspects of central neurodegeneration.. Cell Discov. 10(1):41.
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L.  2024.  Immunosurveillance in clinical cancer management.. CA Cancer J Clin. 74(2):187-202.
de Wit R, Vaughn DJ, Fradet Y, Fong L, Climent MA, Necchi A, Petrylak DP, Gerritsen WR, Gurney H, Quinn DI et al..  2024.  Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial.. Eur Urol.
Buqué A, Bloy N, Petroni G, Jiménez-Cortegana C, Sato A, Iribarren C, Yamazaki T, Galassi C, Hensler M, Bhinder B et al..  2024.  Impact of radiotherapy dose, fractionation and immunotherapeutic partner in a mouse model of HR+ mammary carcinogenesis.. J Natl Cancer Inst.
Gal J, Mosquera JMiguel, Robinson BD, Schlegel PN.  2024.  Incidental seminoma in nonobstructive azoospermia: a case report.. F S Rep. 5(2):211-213.
Chatterjee SS, Linares JF, Cid-Diaz T, Duran A, Khan MImran K, Osrodek M, Brady NJ, Reina-Campos M, Marzio A, Venkadakrishnan VBalaji et al..  2024.  Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer.. Nat Commun. 15(1):9755.
Arnold M, Buyukozkan M, P Doraiswamy M, Nho K, Wu T, Gudnason V, Launer LJ, Wang-Sattler R, Adamski J, De Jager PL et al..  2024.  Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease.. medRxiv.
Schwarz E, Benner B, Wesolowski R, Quiroga D, Good L, Sun SH, Savardekar H, Li J, Jung KJoo, Duggan MC et al..  2024.  Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.. JCI Insight. 9(21)
Wolujewicz P, Aguiar-Pulido V, Thareja G, Suhre K, Elemento O, Finnell RH, M Ross E.  2024.  Integrative computational analyses implicate regulatory genomic elements contributing to spina bifida.. Genet Med Open. 2:101894.
Hissong E, Bhinder B, Kim J, Ohara K, Ravichandran H, Assaad MAl, Elsoukkary S, Shusterman M, Khan U, Eng KWha et al..  2024.  Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival.. Res Sq.
Chen X, Tsvetkov AS, Shen H-M, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon H-U, Galluzzi L, Luo S et al..  2024.  International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis.. Autophagy.
Nguyen DD, Hooper WF, Liu W, Chu TR, Geiger H, Shelton JM, Shah M, Goldstein ZR, Winterkorn L, Helland A et al..  2024.  The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.. Nature. 635(8037):219-228.
Yaron-Barir TM, Joughin BA, Huntsman EM, Kerelsky A, Cizin DM, Cohen BM, Regev A, Song J, Vasan N, Lin T-Y et al..  2024.  The intrinsic substrate specificity of the human tyrosine kinome.. Nature.
Vivelo C, Reilly KM, Widemann BC, Wedekind MFrances, Painter C, O'Neill AF, Mueller S, Elemento O, Gross AM, Sandler AB.  2024.  The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review.. Oncologist. 29(2):106-116.
Charpentier M, Bloy N, Formenti SC, Galluzzi L, Demaria S.  2024.  Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.. J Vis Exp. (206)
Li X-Q, Yamazaki T, He T, Alam MMasud, Liu J, Trivett AL, Sveinbjørnsson B, Rekdal Ø, Galluzzi L, Oppenheim JJ et al..  2024.  LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.. Front Immunol. 15:1332922.
Chaudhry F, Kim TWan, Elemento O, Betel D.  2024.  Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson's Disease.. medRxiv.
Gillessen S, Turco F, Davis ID, Efstathiou JA, Fizazi K, James ND, Shore N, Small E, Smith M, Sweeney CJ et al..  2024.  Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).. Eur Urol.
Montrose DC, Saha S, Galluzzi L.  2024.  Metabolic regulation of the mitochondrial immune checkpoint.. Oncoimmunology. 13(1):2394247.
Pandey RS, Arnold M, Batra R, Krumsiek J, Kotredes KP, Garceau D, Williams H, Sasner M, Howell GR, Kaddurah-Daouk R et al..  2024.  Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.. Alzheimers Dement.
Guilbaud E, Galluzzi L.  2024.  A mitochondrial checkpoint to NF-κB signaling.. Cell Death Dis. 15(7):477.
Galassi C, Klapp V, Yamazaki T, Galluzzi L.  2024.  Molecular determinants of immunogenic cell death elicited by radiation therapy.. Immunol Rev. 321(1):20-32.
Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, Beja K, Mizuno K, Ku S, Fazli L et al..  2024.  Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.. J Natl Cancer Inst. 116(1):115-126.
Beltrán-Visiedo M, Balachandran S, Galluzzi L.  2024.  MRE11 mobilizes CGAS and drives ZBP1-dependent necroptosis.. Cell Res.